Silvercrest Asset Management Group LLC Exagen Inc. Transaction History
Silvercrest Asset Management Group LLC
- $14.1 Billion
- Q1 2024
A detailed history of Silvercrest Asset Management Group LLC transactions in Exagen Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 544,877 shares of XGN stock, worth $991,676. This represents 0.01% of its overall portfolio holdings.
Number of Shares
544,877
Previous 544,877
-0.0%
Holding current value
$991,676
Previous $1.08 Million
20.11%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding XGN
# of Institutions
35Shares Held
6.21MCall Options Held
1.6KPut Options Held
4.1K-
Rtw Investments, LP New York, NY1.5MShares$2.74 Million0.04% of portfolio
-
Cowen And Company, LLC899KShares$1.64 Million0.05% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT787KShares$1.43 Million0.01% of portfolio
-
Perkins Capital Management Inc494KShares$898,2990.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$893,5180.0% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $29.6M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...